Citations

Showing 10 of 108152 citations.

Attacking COVID-19 Progression Using Multi-Drug Therapy for Synergetic Target Engagement
Coban, Matt , Morrison, Juliet , Maharjan, Sushila , Medina, David Hyram Hernandez , Li, Wanlu, Zhang, Yu Shrike , Freeman, William D., Radisky, Evette S. , Roch, Karine G. Le, Weisend, Carla M. , Ebihara, Hideki , Caulfield, Thomas R. , Roch, Karine G. Le , Coban, Mathew A , Hernandez Medina, David Hyram , Caulfield, Thomas R , Ebihara, Hideki , Zhang, Yu Shrike , Radisky, Evette S , Morrison, Juliet , Maharjan, Sushila , Li, Wanlu, Freeman, William D., Weisend, Carla M.

Mayo Clinic

Biomolecules | May 23, 2021 | Volume: 11 | Issue: 6 | Pages: 787

10.3390/biom11060787 | PMID 34071060 Get It

COVID-19 is a devastating respiratory and inflammatory illness caused by a new coronavirus that is rapidly spreading throughout the human population. Over the past 12 months, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus responsible for COVID-19, has already infected over 160 million (>20% located in United States) and killed more than 3.3 million people around the world (>20% deaths in USA). As we face one of the most challenging times in our recent history, there is an urgent need to identify drug candidates that can attack SARS-CoV-2 on multiple fronts. We have therefore initiated a computational dynamics drug pipeline using molecular modeling, structure simulation, docking and machine learning models to predict the inhibitory activity of several million compounds against two essential SARS-CoV-2 viral proteins and their host protein interactors—S/Ace2, Tmprss2, Cathepsins L and K, and Mpro—to prevent binding, membrane fusion and replication of the virus, respectively. All together, we generated an ensemble of structural conformations that increase high-quality docking outcomes to screen over >6 million compounds including all FDA-approved drugs, drugs under clinical trial (>3000) and an additional >30 million selected chemotypes from fragment libraries. Our results yielded an initial set of 350 high-value compounds from both new and FDA-approved compounds that can now be tested experimentally in appropriate biological model systems. We anticipate that our results will initiate screening campaigns and accelerate the discovery of COVID-19 treatments.
Infected Aneurysm of the Native Aorta due to Coccidioides posadasii
Huang, Jeffrey , Cevallos, Edison Cano , Shweta, Fnu , Shah, Aditya , Schuetz, Audrey N. , Bois, Melanie C. , Gurram, Pooja , Cano Cevallos, Edison Jose , Shah, Aditya S , Bois, Melanie, Gurram, Pooja R , Schuetz, Audrey N , Shweta, Fnu

Mayo Clinic

Open Forum Infectious Diseases | May 23, 2021 | Volume: 8 | Issue: 6 | Pages: No page available

10.1093/ofid/ofab266 | PMID 34159219 Get It

Abstract Coccidioidomycosis is an endemic fungal infection that is typically asymptomatic or associated with pulmonary disease. Extrapulmonary disease may involve the skin, bones, or central nervous system, yet endovascular infections are exceedingly rare. We report the first case, to our knowledge, of coccidioidomycosis of the native aorta in an immunocompromised host.
Navigating uncertainty with GRACE: Society for Academic Emergency Medicine’s guidelines for reasonable and appropriate care in the emergency department
Carpenter, Christopher R. , Bellolio, Fernanda , Upadhye, Suneel , Kline, Jeffrey A. , Bellolio, M Fernanda , Carpenter, Christopher R

Mayo Clinic

Academic Emergency Medicine | May 22, 2021 | Volume: 28 | Issue: 7 | Pages: 821-825

10.1111/acem.14297 | PMID 34022076 Get It

After the Temporal Lifting Technique—What comes next?
Hernandez, Claudia A, Schneider, Carolina, Gold, Michael H. , Muniz, Mariana, Alfertshofer, Michael , Frank, Konstantin , Cotofana, Sebastian , Alfertshofer, Michael , Frank, Konstantin , Cotofana, Sebastian , Gold, Michael H , Green, Jeremy B.

Mayo Clinic

Journal of Cosmetic Dermatology | May 22, 2021 | Volume: 20 | Issue: 12 | Pages: 3857-3862

10.1111/jocd.14247 | PMID 34021958 Get It

AbstractBackgroundThe temporal lifting technique can provide lateral facial lifting when administering hyaluronic acid (HA)‐based soft tissue fillers into the subdermal plane of the temple. However, the central facial oval is not influenced by this technique.ObjectivesTo identify the safety and esthetic effectiveness of additional midfacial injection points (in addition to the temporal lifting technique) that can volumize the medial midface, lift the lateral face, and increase jawline contouring when included into a full‐face injection algorithm.MethodsThe patient records of nine consecutive patients (all females) with a mean age of 35.0 (8.4) years and a mean body mass index of 21.7 (2.4) kg/m2 were retrospectively analyzed after a full‐face injection algorithm was performed using HA‐based fillers. The additional injection points target the supraperiosteal plane of the medial zygomatic arch, the lateral infraorbital region, and the pyriform fossa using both needles and cannula.ResultsNo adverse events were observed during the 6‐month retrospective observational period. The volume of the medial midface increased, the volume of the lateral midface decreased, and the contour of the jawline improved; all effects reached a highly statistically significant level with p < 0.001.ConclusionDespite each individual injection is currently performed on a daily clinical basis the evaluated injection algorithm following the temporal lifting technique shows some evidence that it is safe and esthetically effective. Future studies will need to confirm the results presented herein in a larger sample and with objective outcome measures to guide safe and effective esthetic outcomes.
Development of a Competency Model for Placement and Verification of Nasogastric and Nasoenteric Feeding Tubes for Adult Hospitalized Patients
Powers, Jan , Brown, Britta , Lyman, Beth, Escuro, Arlene A. , Linford, Lorraine, Gorsuch, Kim, Mogensen, Kris M. , Engelbrecht, Jessica, Chaney, Amanda , McGinnis, Carol , Quatrara, Beth , Leonard, Jennifer , Guenter, Peggi , Mogensen, Kris M , Escuro, Arlene , Engelbrecht, Jessica

Mayo Clinic

Nutrition in Clinical Practice | May 22, 2021 | Volume: 36 | Issue: 3 | Pages: 517-533

10.1002/ncp.10671 | PMID 34021623 Get It

AbstractNasogastric/nasoenteric (NG/NE) feeding tube placements are associated with adverse events and, without proper training, can lead to devastating and significant patient harm related to misplacement. Safe feeding tube placement practices and verification are critical. There are many procedures and techniques for placement and verification; this paper provides an overview and update of techniques to guide practitioners in making clinical decisions. Regardless of placement technique and verification practices employed, it is essential that training and competency are maintained and documented for all clinicians placing NG/NE feeding tubes. This paper has been approved by the American Society for Parenteral and Enteral Nutrition (ASPEN) Board of Directors.
Development of a self‐directed sinonasal surgical anatomy video curriculum: Phase 1 validation
Bailey, Christopher E. , Grauer, Jordan , Rangarajan, Sanjeet V., Tewfik, Marc A. , Marino, Michael J. , Torabi, Mohammad R. , Le, Christopher H. , Chang, Eugene H. , Bailey, C Eric , Rangarajan, Sanjeet V , Chen, Philip G. , Chan, Yvonne , Torabi, Mohammad

Mayo Clinic

International Forum of Allergy & Rhinology | May 22, 2021 | Volume: 11 | Issue: 11 | Pages: 1570-1576

10.1002/alr.22814 | PMID 34021535 Get It

BackgroundSinusitis is a common outpatient diagnosis made by physicians and is a reason for referral to otolaryngologists. A foundation in basic sinonasal anatomy is critical in understanding sinus pathophysiology and avoiding complications. Our objective in this study was to develop and to validate a self‐directed surgical anatomy video for medical students.MethodsTwo multimedia videos were developed highlighting sinonasal anatomy. In Video 1 we included audio narration and radiologic imaging. Video 2 incorporated highlighted images from a sinus surgery video. An assessment was developed to test sinonasal anatomy landmarks, spatial recognition of structures, and their clinical relevance. An expert panel of rhinologists scored face and content validity of the curriculum videos and assessment. Factor analysis was used to separate questions into face and content validity domains, and a one‐sample t test was performed.ResultsThe panel scored face validity (Videos 1 and 2: 4.4/5) and content validity (Video 1: 4.5/5, 0.83; Video 2: 4.3/5, 0.75) significantly higher than a neutral response. There were no statistical differences for face or content validity between videos. The assessment was rated suitable (29%) or very suitable (57%) for testing basic sinonasal surgical anatomy, and the majority (71%) of respondents agreed (14%) or strongly agreed (57%) that the assessment thoroughly covered the sinus anatomy content with which medical students should be familiar.ConclusionWe have developed two videos and an assessment that highlight and test sinonasal anatomy. Future studies will aim to identify whether the use of a self‐directed video curriculum improves sinonasal anatomy awareness and whether incorporation of surgical endoscopic videos augments training.
Patient experience of telemedicine for headache care during the COVID‐19 pandemic: An American Migraine Foundation survey study
Chiang, Chia‐Chun , Lalvani, Nim, Stein, Ken , Lorenz, Deborah Henscheid, Lay, Christine , Newman, Lawrence C. , Halker Singh, Rashmi, Chiang, Chia-Chun , Singh, Rashmi B. Halker , Stein, Ken Shubin, Lay, Christine L. , Dodick, David W.

Mayo Clinic

Headache: The Journal of Head and Face Pain | May 22, 2021 | Volume: 61 | Issue: 5 | Pages: 734-739

10.1111/head.14110 | PMID 34021595 Get It

Abstract Objective We sought to investigate the patient experience of telemedicine for headache care during the coronavirus disease 2019 (COVID‐19) pandemic. Background The use of telemedicine has rapidly expanded and evolved since the beginning of the COVID‐19 pandemic. Telemedicine eliminates the physical and geographic barriers to health care, preserves personal protective equipment, and prevents the spread of COVID‐19 by allowing encounters to happen in a socially distanced way. However, few studies have assessed the patient perspective of telemedicine for headache care. Methods The American Migraine Foundation (AMF) designed a standardized electronic questionnaire to assess the patient experience of telemedicine for headache care between March and September 2020 to help inform future quality improvement as part of its patient advocacy initiative. The date parameters were identified as the emergence of severe acute respiratory syndrome coronavirus 2 disease and the declaration of a national emergency in the United States. The questionnaire was distributed electronically to more than 100,000 members of the AMF community through social media platforms and the AMF email database. Results A total of 1172 patients responded to our electronic questionnaire, with 1098 complete responses. The majority, 1081/1153 (93.8%) patients, had a previous headache diagnosis prior to the telemedicine encounter. A total of 648/1127 (57.5%) patients reported that they had used telemedicine for headache care during the study period. Among those who participated in telehealth visits, 553/647 (85.5%) patients used it for follow‐up visits; 94/647 (14.5%) patients used it for new patient visits. During the telemedicine encounters, 282/645 (43.7%) patients were evaluated by headache specialists, 222/645 (34.4%) patients by general neurologists, 198/645 (30.7%) patients by primary care providers, 73/645 (11.3%) patients by headache nurse practitioners, and 21/645 (3.2%) patients by headache nurses. Only 47/633 (7.4%) patients received a new headache diagnosis from telemedicine evaluation, whereas the other 586/633 (92.6%) patients did not have a change in their diagnoses. During these visits, a new treatment was prescribed for 358/636 (52.3%) patients, whereas 278/636 (43.7%) patients did not have changes made to their treatment plan. The number (%) of patients who rated the telemedicine headache care experience as “very good,” “good,” “fair,” “poor,” and “other” were 396/638 (62.1%), 132/638 (20.7%), 67/638 (10.5%), 23/638 (3.6%), and 20/638 (3.1%), respectively. Detailed reasons for “other” are listed in the manuscript. Most patients, 573/638 (89.8%), indicated that they would prefer to continue to use telemedicine for their headache care, 45/638 (7.1%) patients would not, and 20/638 (3.1%) patients were unsure. Conclusions Our study evaluating the patient perspective demonstrated that telemedicine facilitated headache care for many patients during the COVID‐19 pandemic, resulting in high patient satisfaction rates, and a desire to continue to use telemedicine for future headache care among those who completed the online survey.
Secondary Cytoreduction and Carboplatin Hyperthermic Intraperitoneal Chemotherapy for Platinum-Sensitive Recurrent Ovarian Cancer: An MSK Team Ovary Phase II Study
Zivanovic, Oliver , Zhou, Qin , Iasonos, Alexia , Makker, Vicky , Brown, Amy, Nerenstone, Stacy, Schroeder, E.D., Soldan, Krysten, Su, Katy , Gardner, Ginger J. , Andikyan, Vaagn , Guo, Jianxia , Jewell, Elizabeth L. , Roche, Kara Long , Troso-Sandoval, Tiffany A. , Lichtman, Stuart M. , Moukarzel, Lea A. , Dessources, Kimberly , Abu‐Rustum, Nadeem R. , Aghajanian, Carol , Tew, William P. , Sonoda, Yukio, Iasonos, Alexia , Konner, Jason A , Makker, Vicky , Langstraat, Carrie L , Paroder, Viktoriya , Lakhman, Yulia , Su, Katy , Gardner, Ginger J , Jewell, Elizabeth L , Troso-Sandoval, Tiffany , Lichtman, Stuart M , Tew, William P , Beumer, Jan Hendrik , Sonoda, Yukio , O'Cearbhaill, Roisin E , Moukarzel, Lea A , Dennis, S. , Grisham, Rachel Nicole , Diaz, John Paul , Langstraat, Carrie , Lakhman, Yulia

Mayo Clinic

Journal of Clinical Oncology | May 21, 2021 | Volume: 39 | Issue: 23 | Pages: 2594-2604

10.1200/jco.21.00605 | PMID 34019431 Get It

PURPOSEThe purpose of this phase II study was to evaluate hyperthermic intraperitoneal chemotherapy (HIPEC) with carboplatin for recurrent ovarian cancer during secondary cytoreductive surgery.MATERIALS AND METHODSPatients were intraoperatively randomly assigned to carboplatin HIPEC (800 mg/m2for 90 minutes) or no HIPEC, followed by five or six cycles of postoperative IV carboplatin-based chemotherapy, respectively. Based on a binomial single-stage pick-the-winner design, an arm was considered winner if ≥ 17 of 49 patients were without disease progression at 24 months post-surgery. Secondary objectives included postoperative toxicity and HIPEC pharmacokinetics.RESULTSOf 98 patients, 49 (50%) received HIPEC. Complete gross resection was achieved in 82% of the HIPEC patients and 94% of the standard-arm patients. Bowel resection was performed in 37% of patients in the HIPEC arm compared with 65% in the standard ( P = .008). There was no perioperative mortality and no difference in use of ostomies, length of stay, or postoperative toxicity. At 24 months, eight patients (16.3%; 1-sided 90% CI, 9.7 to 100) were without progression or death in the HIPEC arm and 12 (24.5%; 1-sided 90% CI, 16.5 to 100) in the standard arm. With a medium follow-up of 39.5 months, 82 patients progressed and 37 died. The median progression-free survival in the HIPEC and standard arms were 12.3 and 15.7 months, respectively (hazard ratio, 1.54; 95% CI, 1 to 2.37; P = .05). There was no significant difference in median overall survival (52.5 v 59.7 months, respectively; hazard ratio, 1.39; 95% CI, 0.73 to 2.67; P = .31). These analyses were exploratory.CONCLUSIONHIPEC with carboplatin was well tolerated but did not result in superior clinical outcomes. This study does not support the use of HIPEC with carboplatin during secondary cytoreductive surgery for platinum-sensitive recurrent ovarian cancer.
Liposuction and Patient Safety: Appropriately Credentialing Providers
Teven, Chad M. , TerKonda, Sarvam P. , Martinez‐Jorge, Jorys, Rebecca, Alanna M. , Mardini, Samir

Mayo Clinic

Plastic & Reconstructive Surgery | May 21, 2021 | Volume: 147 | Issue: 6 | Pages: 1087e-1088e

10.1097/prs.0000000000007970 | PMID 34019526 Get It

Does Reduction Mammaplasty for Treatment of Macromastia Play a Role in the Functionality and Performance of Female Athletes?
Kaplan, Jamie L. , Forte, Antonio J. , Kaplan, Jamie, Forte, Antonio Jorge

Mayo Clinic

Plastic & Reconstructive Surgery | May 21, 2021 | Volume: 147 | Issue: 6 | Pages: 1084e-1084e

10.1097/prs.0000000000007921 | PMID 34019524 Get It